Page last updated: 2024-11-04

sulfamonomethoxine and Cancer of Liver

sulfamonomethoxine has been researched along with Cancer of Liver in 1 studies

Sulfamonomethoxine: Long acting sulfonamide antibacterial agent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Niu, Y1
Lin, Z1
Wan, A1
Sun, L1
Yan, S1
Liang, H1
Zhan, S1
Chen, D1
Bu, X1
Liu, P1
Chen, C1
He, W1
Lu, X1
Wan, G1

Other Studies

1 other study available for sulfamonomethoxine and Cancer of Liver

ArticleYear
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:3

    Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor;

2021